Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.49, $0.05 better than the analyst estimate of $0.44. Revenue for the quarter came in at $20.4 million versus the consensus estimate of $20.01 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.